Literature DB >> 16416388

Neurodegeneration and oxidative stress: prion disease results from loss of antioxidant defence.

David R Brown1.   

Abstract

Prion diseases or transmissible spongiform encephalopathies (TSEs) are rare neurodegenerative disorders that can be acquired either by direct transmission, inherited through dominant mutations in the prion protein gene or via an unknown sporadic cause. This latter group constitutes the vast majority of cases. Like many neurodegenerative diseases the hallmarks of oxidative damage can be readily detected throughout the brain of the affected individual. However, unlike most other neurodegenerative diseases, prion diseases are connected with a dramatic loss of antioxidant defence. As abnormal protein accumulates in the diseased brain there is both an increase of oxidative substances and a loss of the defences that keep them in check. In particular the normal cellular prion protein has been shown to be an antioxidant. Conversion of this protein to the protease resistant isoform is accompanied by a loss of this antioxidant activity. This change creates a paradox as the loss of activity is not accompanied by a loss of protein expression. It is likely that this prevents other cellular defences from responding sufficiently to protect neurons from the heightened oxidative burden. Recent experiments with transgenic mice have shown that when prion protein expression is switched off during the course of prion disease, cell death is dramatically halted and the mouse recovers from the disease. This result clearly illustrates that the continued expression of non-function prion protein is essential for disease progression. This implies that the presence of this abnormal protein during prion disease causes a failure of cellular antioxidant defence. This failed defence is the fundamental cause of the massive neurodegeneration that results in the fatal nature of TSEs. The role of oxidative stress in TSEs and other neurodegenerative disorders are discussed in this review.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16416388

Source DB:  PubMed          Journal:  Folia Neuropathol        ISSN: 1509-572X            Impact factor:   2.038


  31 in total

Review 1.  Clioquinol: review of its mechanisms of action and clinical uses in neurodegenerative disorders.

Authors:  Silvio R Bareggi; Umberto Cornelli
Journal:  CNS Neurosci Ther       Date:  2010-12-27       Impact factor: 5.243

2.  Cellular prion protein (PrP(C)) and its role in stress responses.

Authors:  Liang Zeng; Wenquan Zou; Gongxian Wang
Journal:  Int J Clin Exp Med       Date:  2015-05-15

Review 3.  Metabolic and structural role of thiamine in nervous tissues.

Authors:  Abdoulaye Bâ
Journal:  Cell Mol Neurobiol       Date:  2008-07-19       Impact factor: 5.046

4.  Prnp gene and cerebellum volume in patients with refractory mesial temporal lobe epilepsy.

Authors:  Michelle N Valadão; Erica R Coimbra; Michele C Landemberger; Tonicarlo R Velasco; Vera C Terra; Lauro Wichert-Ana; Veriano Alexandre; David Araújo; Ricardo Guarnieri; Vilma R Martins; Antônio Carlos Santos; Américo C Sakamoto; Roger Walz
Journal:  Neurol Sci       Date:  2013-10-05       Impact factor: 3.307

5.  Impact of methionine oxidation as an initial event on the pathway of human prion protein conversion.

Authors:  Mohammed I Y Elmallah; Uwe Borgmeyer; Christian Betzel; Lars Redecke
Journal:  Prion       Date:  2013-10-09       Impact factor: 3.931

6.  Alterations in neuronal metabolism contribute to the pathogenesis of prion disease.

Authors:  Julie-Myrtille Bourgognon; Jereme G Spiers; Hannah Scheiblich; Alexey Antonov; Sophie J Bradley; Andrew B Tobin; Joern R Steinert
Journal:  Cell Death Differ       Date:  2018-06-18       Impact factor: 15.828

7.  Neuroimmunoendocrine regulation of the prion protein in neutrophils.

Authors:  Rafael M Mariante; Alberto Nóbrega; Rodrigo A P Martins; Rômulo B Areal; Maria Bellio; Rafael Linden
Journal:  J Biol Chem       Date:  2012-08-21       Impact factor: 5.157

8.  Oxidation of Helix-3 methionines precedes the formation of PK resistant PrP.

Authors:  Tamar Canello; Kati Frid; Ronen Gabizon; Silvia Lisa; Assaf Friedler; Jackob Moskovitz; María Gasset; Ruth Gabizon
Journal:  PLoS Pathog       Date:  2010-07-01       Impact factor: 6.823

9.  Role of proteolytic activation of protein kinase Cδ in the pathogenesis of prion disease.

Authors:  Dilshan S Harischandra; Naveen Kondru; Dustin P Martin; Arthi Kanthasamy; Huajun Jin; Vellareddy Anantharam; Anumantha G Kanthasamy
Journal:  Prion       Date:  2014 Jan-Feb       Impact factor: 3.931

10.  Cellular and biochemical actions of melatonin which protect against free radicals: role in neurodegenerative disorders.

Authors:  Genaro G Ortiz; Gloria A Benítez-King; Sergio A Rosales-Corral; Fermín P Pacheco-Moisés; Irma E Velázquez-Brizuela
Journal:  Curr Neuropharmacol       Date:  2008-09       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.